New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Biking, Prostate Cancer Risk Investigated

Cyclists who bike more may face a higher risk of prostate cancer, but not a greater chance of infertility or erectile dysfunction.

Could Statins Cut Breast Cancer Risk?

Women with hyperlipidemia have an increased risk of developing breast cancer, according to a new study.

Vaccine-Chemo for Pancreatic Cancer

The results of a new trial are extremely promising for the efficacy of a vaccine-chemotherapy combination for pancreatic cancer.

Novel Gene Mutations and Lung Cancer

Researchers have identified genetic mutations in the cell signaling pathway RTK/RAS/RAF that can lead to lung adenocarcinoma.

Corticosteroids for Cancer Pain?

Even with limited evidence as to their efficacy, corticosteroids are often included in cancer pain management therapy.

No Fertility Drug-Cancer Link

Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

InnoPharma Approved for Generic Dacogen

InnoPharma has announced that it has received approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Decitabine for Injection, a generic version of Eisai's Dacogen.

Pioglitazone, Bladder Cancer Risk: No Link in 10-Year Study

Pioglitazone, Bladder Cancer Risk: No Link in 10-Year Study

Takeda announced their completion and data submission of a 10-year epidemiology study to regulatory authorities, including the United States Food and Drug Administration (FDA).

Depression in Cancer Patients Often Untreated

Depression in Cancer Patients Often Untreated

Patients with cancer and depression frequently do not receive effective treatment, but an integrated program is effective in patients with cancer, specifically lung cancer.

Sensory Deficits Common in Multiple Myeloma

Sensory Deficits Common in Multiple Myeloma

Treatment-naive patients with multiple myeloma (MM) frequently have sensory deficits, which seem to result from disease-related decreases in peripheral innervation densit.

Molecular Method Classifies Patients With Polycythemia Vera

Molecular Method Classifies Patients With Polycythemia Vera

Patients with polycythemia vera can be classified according to disease behavior, independently of Janus kinase 2 (JAK2) V617F allele burden, after removing sex as a potential confounder.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Sign Up for Free e-newsletters